Anna C. Geraghty

Howard Hughes Medical Institute — United States

Medicine · Health Sciences

19h-index5.9kcitations43works9.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(8), Neurogenesis and neuroplasticity mechanisms(7), Neuroinflammation and Neurodegeneration Mechanisms(7), Stress Responses and Cortisol(6), Hypothalamic control of reproductive hormones(6)

Publications43 total

Dysregulated Microglial Synaptic Engulfment in Diffuse Midline Glioma
2025Open Access
Environmental factors contribute to cancer therapy toxicity
2025
CNSC-68. LEVETIRACETAM THERAPEUTICALLY TARGETS GABAERGIC SYNAPSES IN DIFFUSE MIDLINE GLIOMA
Neuro-Oncology·2025Open Access
CNSC-72. ADRENERGIC NEURONS OF THE LOCUS COERULEUS PROMOTE DIFFUSE MIDLINE GLIOMA GROWTH
Neuro-Oncology·2025Open Access
EXTH-138. GD2 as an Immunotherapeutic Target in Oligodendroglioma: Preclinical Evidence Supporting CAR T Cell Therapy
Neuro-Oncology·2025Open Access
Neuroligin-3 interaction with CSPG4 regulates normal and malignant glial precursors through PIEZO1
2025Open Access
Immunotherapy-related cognitive impairment after CAR T cell therapy in mice
Cell·2025· 25 citedOpen Access
GABAergic neuron-to-glioma synapses in diffuse midline gliomas
Nature·2025· 75 citedOpen Access
IMMU-60. MYELOID POPULATIONS MODULATE GD2 CAR T CELL ACTIVITY IN DIFFUSE MIDLINE GLIOMA
Neuro-Oncology·2024· 1 citedOpen Access
Immunotherapy-related cognitive impairment after CAR T cell therapy in mice
2024· 2 citedOpen Access
Investigating biomarkers and therapeutic approaches in mouse models of SARS-CoV2 induced Long COVID with neuroinflammation and cognitive deficits.
The Journal of Immunology·2024
Glioma synapses recruit mechanisms of adaptive plasticity
Nature·2023· 214 citedOpen Access
Distinguishing features of long COVID identified through immune profiling
Nature·2023· 618 citedOpen Access
Abstract PR003: Lineage plasticity dictates responsiveness to anti-GD2 therapy in neuroblastoma
Cancer Research·2022
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
Nature Cancer·2022· 100 citedOpen Access
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation
Cell·2022· 482 citedOpen Access
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Nature·2022· 740 citedOpen Access
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
Nature Medicine·2022· 240 citedOpen Access
TAMI-28. IDENTIFICATION OF A NEUROLIGIN-3 BINDING PARTNER IN HIGH-GRADE GLIOMAS AND NORMAL PROGENITORS
Neuro-Oncology·2021Open Access
HGG-05. NEURONAL ACTIVITY PROMOTES PEDIATRIC HIGH-GRADE GLIOMA GROWTH THROUGH A NLGN3-CSPG4 SIGNALING AXIS
Neuro-Oncology·2021Open Access
page 1 of 3Next →

Frequent Co-authors

Michelle Monje(32), Pamelyn J. Woo(15), Lijun Ni(11), Shawn Gillespie(10), Hannes Vogel(10), Rebecca Mancusi(10), Daniela Kaufer(8), Humsa S. Venkatesh(7), Kathryn R. Taylor(7), Mario L. Suvà(7), Robbie G. Majzner(7), Kiarash Shamardani(7), Lydia Tam(6), Michael A. Quezada(6), Wade Morishita(5), Aviv Regev(5), Maria Caterina Rotiroti(5), Belgin Yalçın(5), George E. Bentley(5), Tara Barron(5)